These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20595686)

  • 1. The role of SATB1 in breast cancer pathogenesis.
    Iorns E; Hnatyszyn HJ; Seo P; Clarke J; Ward T; Lippman M
    J Natl Cancer Inst; 2010 Aug; 102(16):1284-96. PubMed ID: 20595686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SATB1 gene expression and breast cancer prognosis.
    Hanker LC; Karn T; Mavrova-Risteska L; Ruckhäberle E; Gaetje R; Holtrich U; Kaufmann M; Rody A; Wiegratz I
    Breast; 2011 Aug; 20(4):309-13. PubMed ID: 20980149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new path to the cancer epigenome.
    Richon VM
    Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo.
    Pavan Kumar P; Purbey PK; Sinha CK; Notani D; Limaye A; Jayani RS; Galande S
    Mol Cell; 2006 Apr; 22(2):231-43. PubMed ID: 16630892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron.
    Li K; Cai R; Dai BB; Zhang XQ; Wang HJ; Ge SF; Xu WR; Lu J
    Biochem Biophys Res Commun; 2007 Apr; 356(1):6-12. PubMed ID: 17343824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
    Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
    Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.
    McInnes N; Sadlon TJ; Brown CY; Pederson S; Beyer M; Schultze JL; McColl S; Goodall GJ; Barry SC
    Oncogene; 2012 Feb; 31(8):1045-54. PubMed ID: 21743493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
    Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors.
    Alaoui-Jamali MA; Song DJ; Benlimame N; Yen L; Deng X; Hernandez-Perez M; Wang T
    Cancer Res; 2003 Jul; 63(13):3764-74. PubMed ID: 12839972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
    Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
    Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
    Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.